Health Insurance Innovations price target raised to $50 from $40 at Lake Street
Lake Street analyst Mark Argento raised his price target for Health Insurance Innovations to $50 from $40 and reiterates a Buy rating on the shares. While the company's Q3 sales were lower than estimates, driven by a slower than anticipated ramp of the new BPO centers focused on Medicare offerings, its profitability was strong, Argento tells investors in a research note. He reiterates a Buy rating on the shares
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.